Scarica l'app Stockscreener
13.07
4.06%
0.51
Dopo l'orario di chiusura:
12.90
-0.17
-1.30%
Precedente Chiudi:
$12.56
Aprire:
$12.52
Volume 24 ore:
81,449
Relative Volume:
0.66
Capitalizzazione di mercato:
$449.01M
Reddito:
$7,000
Utile/perdita netta:
$-41.54M
Rapporto P/E:
-14.07
EPS:
-0.929
Flusso di cassa netto:
$-20.57M
1 W Prestazione:
-5.15%
1M Prestazione:
+2.27%
6M Prestazione:
+26.22%
1 anno Prestazione:
+0.46%
Intervallo 1D:
$11.88
$13.19
Intervallo di 1 settimana:
$11.88
$13.96
Portata 52W:
$9.85
$16.76
Benitec Biopharma Inc Stock (BNTC) Company Profile
Nome
Benitec Biopharma Inc
Settore
Industria
Telefono
(510) 780-0819
Indirizzo
3940 TRUST WAY, HAYWARD, CA
Compare BNTC vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
13.07 | 431.49M | 7,000 | -41.54M | -20.57M | -0.929 |
VRTX
Vertex Pharmaceuticals Inc
|
515.55 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.93 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
987.84 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
212.00 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.51 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-07 | Iniziato | TD Cowen | Buy |
| 2024-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-13 | Iniziato | Robert W. Baird | Outperform |
| 2024-10-16 | Iniziato | Oppenheimer | Outperform |
| 2024-09-12 | Iniziato | Guggenheim | Buy |
| 2024-07-22 | Iniziato | Leerink Partners | Outperform |
| 2024-06-13 | Iniziato | Piper Sandler | Overweight |
| 2020-10-05 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-02-26 | Downgrade | Maxim Group | Buy → Hold |
| 2015-12-31 | Reiterato | Maxim Group | Buy |
| 2015-09-16 | Reiterato | Maxim Group | Buy |
Mostra tutto
Benitec Biopharma Inc Borsa (BNTC) Ultime notizie
Trading Systems Reacting to (BNTC) Volatility - Stock Traders Daily
Benitec Biopharma (NASDAQ:BNTC) Share Price Crosses Above 50 Day Moving AverageTime to Sell? - marketbeat.com
Benitec Biopharma Inc (BNTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Companies Like Benitec Biopharma (NASDAQ:BNTC) Can Afford To Invest In Growth - Moomoo
Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation - Sahm
How Benitec Biopharma Inc. (BNTC) Affects Rotational Strategy Timing - Stock Traders Daily
Benitec Biopharma (BNTC) Slips 1.26% as Shares Test Key Support at $11.12Factor Crowding - dars.gov.et
Benitec Biopharma (NASDAQ:BNTC) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Benitec Biopharma Inc (BNTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BNTC Initiated by Wedbush -- Rating Set to Outperform with PT at $16.00 - GuruFocus
Wedbush Initiates Coverage on Benitec Biopharma (BNTC) with Outp - GuruFocus
Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Benitec Biopharma Inc (BNTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Benitec Biopharma Inc (BNTC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BNTC|Benitec Biopharma Inc|Price:11.710|Chg%:+0.240 - TradingKey
Benitec Biopharma Inc (BNTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BNTC|Benitec Biopharma Inc|Price:11.540|Chg%:+0.070 - TradingKey
TradingKey - TradingKey
Benitec Biopharma Inc (BNTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BNTC|Benitec Biopharma Inc|Price:11.470|Chg%:+0.030 - TradingKey
Benitec Biopharma Inc (BNTC) Institutional Confidence - TradingKey
(BNTC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Benitec Biopharma (BNTC) Retraces 1.72% – Navigating Key Support and Resistance LevelsFibonacci Time Zone - dars.gov.et
Benitec Biopharma (NASDAQ:BNTC) Stock Price Passes Above Fifty Day Moving AverageWhat's Next? - MarketBeat
BNTC Q2 2026 Earnings: Narrowed Loss Beats Expectations Amid Pipeline ProgressEarnings Trend Analysis - dars.gov.et
BNTC Q2 2026 Earnings: Narrower Loss Exceeds Expectations; Stock Slightly LowerEarnings Trend Analysis - dars.gov.et
Price to sales forward of Benitec Biopharma Inc. – NASDAQ:BNTC - TradingView
BNTCBenitec Biopharma Inc Latest SEC Filings - Finviz
BNTC Stock Price, Quote & Chart - ChartMill
Form 4 Benitec Biopharma Ltd ADR For: 30 June By Investing.com - Investing.com Nigeria
Responsive Playbooks and the BNTC Inflection - Stock Traders Daily
Benitec Biopharma (NASDAQ: BNTC) director gifts 51,813 shares to donor-advised fund - Stock Titan
Benitec Biopharma Inc.(NasdaqCM: BNTC) added to Russell 2000 Value Benchmark - marketscreener.com
Benitec Biopharma Inc.(NasdaqCM:BNTC) added to Russell Microcap Value Benchmark Index - marketscreener.com
Benitec Biopharma Inc.(NasdaqCM:BNTC) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Benitec Biopharma Inc.(NasdaqCM: BNTC) added to Russell 3000E Value Benchmark - marketscreener.com
Benitec Biopharma Inc Actuals & Estimates (NASDAQ:BNTC) - TradingView
BNTC Forecast — Price Target — Prediction for 2027 - TradingView
Benitec Biopharma Inc (BNTC) Valuation: PE, PB & Fair Value Analysis - TradingKey
BNTC Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive SentimentEarnings Weakness Phase - po-news-eg.net
Understanding the Setup: (BNTC) and Scalable Risk - Stock Traders Daily
Benitec Biopharma Inc (BNTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Benitec Biopharma (BNTC) Faces Downgrade Amid Uncertainty - GuruFocus
Guggenheim Downgrades Benitec Biopharma(BNTC.US) to Hold Rating - Moomoo
The Technical Signals Behind (BNTC) That Institutions Follow - Stock Traders Daily
BNTC Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline Amid Clinical ProgressInterim Report - newsline.com
Benitec Biopharma (BNTC) Slides 2.22% as Shares Approach Critical SupportSentiment Shift - dars.gov.et
Benitec Biopharma (BNTC) Stays Flat: Technical Trading Range Defines Near-Term OutlookGamma Flip Level - The Legal Advocate
Benitec Biopharma Announces Board Changes and New Director - The Globe and Mail
Benitec BiopharmaCFO Megan Boston Resigns From Board Effective May 22, 2026 - TradingView
Benitec Biopharma Inc Azioni (BNTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Benitec Biopharma Inc Azioni (BNTC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '25 |
Buy |
12.85 |
50,000 |
642,500 |
9,620,075 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 26 '25 |
Buy |
13.10 |
16,836 |
220,552 |
9,634,395 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 22 '25 |
Buy |
12.08 |
19,542 |
236,067 |
9,577,475 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 19 '25 |
Buy |
11.48 |
16,384 |
188,088 |
9,560,825 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 18 '25 |
Buy |
11.24 |
10,215 |
114,817 |
9,546,875 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 07 '25 |
Buy |
13.50 |
1,481,481 |
19,999,994 |
9,538,175 |
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):